Extensive white matter abnormalities in early schizophrenia

NewsGuard 100/100 Score

By Mark Cowen, Senior medwireNews Reporter

Patients with first-episode schizophrenia (FES) exhibit widespread white matter abnormalities, results from a brain imaging study show.

Sang-Hyuk Lee (CHA University, Seongnam Kyounggi, South Korea) and team also found a positive correlation between white matter values in a number of brain regions, positive and negative symptoms, and executive function.

"Based on our results, we suggest that extensive white matter pathology is already extant in FES," they write in Schizophrenia Research.

The findings come from a diffusion tensor imaging study of 17 FES patients and 17 age- and gender-matched mentally healthy controls.

Using a tract-based spatial statistics approach, white matter fractional anisotropy (FA) values, and mean (MD), axial (AD), and radial diffusivity (RD) were compared between the groups.

The researchers found that, compared with controls, FES patients showed reduced FA values in the genu and body of the corpus callosum, the internal capsule, the external capsule, the fornix, the superior and inferior fronto-occipital fasciculus, the cingulum, and the uncinate fasciculus.

FES patients also showed increased MD and AD in almost all brain regions compared with controls, although there were no significant between-group differences in RD.

Further analysis showed a significant positive correlation between FA values in the right inferior fronto-occipital fasciculus and positive and negative symptoms, as assessed using the Brief Psychiatric Rating Scale, as well as with total correct items on the Wisconsin Card Sorting Test (WCST) of executive function.

There was also a positive correlation between FA values in the right external capsule and category completed scores on the WCST.

Lee et al conclude: "Our findings suggest extensive white matter abnormalities in FES, which are most likely related to disruptions in myelin integrity."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify the most harmful modifiable risk factors for dementia